Key Insights

Highlights

Success Rate

97% trial completion (above average)

Published Results

26 trials with published results (25%)

Research Maturity

75 completed trials (73% of total)

Clinical Risk Assessment

Based on trial outcomes

Moderate Risk

Score: 40/100

Termination Rate

1.9%

2 terminated out of 103 trials

Success Rate

97.4%

+10.9% vs benchmark

Late-Stage Pipeline

24%

25 trials in Phase 3/4

Results Transparency

35%

26 of 75 completed with results

Key Signals

26 with results97% success

Data Visualizations

Phase Distribution

97Total
Not Applicable (29)
P 1 (13)
P 2 (30)
P 3 (15)
P 4 (10)

Trial Status

Completed75
Unknown17
Recruiting3
Not Yet Recruiting2
Terminated2
Active Not Recruiting2

Trial Success Rate

97.4%

Benchmark: 86.5%

Based on 75 completed trials

Clinical Trials (103)

Showing 20 of 20 trials
NCT06485505Phase 1RecruitingPrimary

Isotretinoin Versus Excimer Light an Adjuvant in Treating Onychomycosis

NCT05202366Completed

An Open-label Study Evaluating the Effectiveness of CGB-400 Topical Gel for Fungal Infection

NCT06689852Not ApplicableRecruitingPrimary

CLINICAL INVESTIGATION FOR THE EVALUATION OF EFFICACY AND SAFETY OF TWO PRODUCTS FOR THE TREATMENT OF ONYCHOMYCOSIS

NCT07033962Not ApplicableNot Yet RecruitingPrimary

Fractional CO₂ Laser or 40% Urea With Topical Fluconazole Microemulsion in Onychomycosis

NCT06327295Phase 2RecruitingPrimary

A Study of ATB1651 in Adults With Mild to Moderate Onchomycosis

NCT00233493CompletedPrimary

Spread of Dermatophytes Among Families

NCT06175013Not ApplicableNot Yet RecruitingPrimary

Evaluation of a Combination of Two Medical Devices and One Device Use in the Treatment of Toenail Onychomycosis

NCT05279846Phase 3Active Not RecruitingPrimary

A Vehicle-controlled Study of Topical MOB015B in the Treatment of Distal Subungual Onychomycosis (DSO)

NCT05626270Not ApplicableCompletedPrimary

Human Factors Testing for OTC Use of the Erchonia® LunulaLaser

NCT05482763Active Not RecruitingPrimary

Mycosis Culture Collection From Dermatological Isolated

NCT02022215Phase 2CompletedPrimary

Efficacy and Safety Study of ME1111 in Patients With Onychomycosis

NCT06254027Not ApplicableUnknownPrimary

Clinical Investigation for the Evaluation of Efficacy and Safety of Two Medical Devices for Onychomycosis Treatment

NCT06074315Not ApplicableUnknown

Evaluation of the Effectiveness of Nail Genesis DLSO Product for Onychomycosis

NCT04993066Not ApplicableCompleted

Clinical Evaluation to Assess the Safety and Efficacy of GentleMax Pro Plus

NCT05089409Phase 1CompletedPrimary

A Study of ATB1651 in Adults With Mild to Moderate Onychomycosis

NCT05560841Not ApplicableCompletedPrimary

Effectiveness and Safety of Nailner Brush 2in1 in Onychomycosis

NCT05491603Phase 2SuspendedPrimary

A Trial to Evaluate the Safety and Efficacy of DBI-001 Gel, DBI-002 Gel, and Aqueous Gel in Subjects With Onychomycosis

NCT05809297Phase 4UnknownPrimary

Diode Laser and Photodynamic Therapy Vs. Ciclopirox.

NCT05578950Phase 1CompletedPrimary

Comparative Study Between Pulse Therapy With Oral Itraconazole Versus Continuous Oral Terbinafine Therapy for Treatment of Onychomycosis

NCT05415852Not ApplicableUnknownPrimary

Lasers in Onychomycosis

Scroll to load more

Research Network

Activity Timeline